Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Jaroch

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Chemmedchem|November 9, 2006
A soluble amyloid fibril segment to study aggregate formationStefan Jaroch
Nature Chemical Biology|January 13, 2006
Putting small molecules in the leadStefan Jaroch, Hilmar Weinmann
Handbook of Experimental Pharmacology|May 26, 2016
The last decade has seen many exciting new medicines being introduced to the market. IntroductionUlrich Nielsch, Ulrike Fuhrmann, Stefan Jaroch
Chemmedchem|July 4, 2007
Asymmetric organocatalysisStefan Jaroch, Hilmar Weinmann, Kirsten Zeitler
Ernst Schering Foundation Symposium Proceedings|August 15, 2008
Organocatalysis. Berlin, April 2007. PrefaceManfred T Reetz, Benjamin List, Stefan Jaroch, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Dihydroquinolines as novel n-NOS inhibitorsStefan Jaroch, Peter Hölscher, Hartmut Rehwinkel, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitorsStefan Jaroch, Peter Hölscher, Hartmut Rehwinkel, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Discovery of quinolines as selective glucocorticoid receptor agonistsStefan Jaroch, Markus Berger, Christoph Huwe, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2017
Discovery of new selective glucocorticoid receptor agonist leadsMarkus Berger, Hartmut Rehwinkel, Norbert Schmees, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Fluorinated dihydroquinolines as potent n-NOS inhibitorsStefan Jaroch, Hartmut Rehwinkel, Peter Hölscher, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Chemmedchem|November 9, 2006
A soluble amyloid fibril segment to study aggregate formationStefan Jaroch
Nature Chemical Biology|January 13, 2006
Putting small molecules in the leadStefan Jaroch, Hilmar Weinmann
Handbook of Experimental Pharmacology|May 26, 2016
The last decade has seen many exciting new medicines being introduced to the market. IntroductionUlrich Nielsch, Ulrike Fuhrmann, Stefan Jaroch
Chemmedchem|July 4, 2007
Asymmetric organocatalysisStefan Jaroch, Hilmar Weinmann, Kirsten Zeitler
Ernst Schering Foundation Symposium Proceedings|August 15, 2008
Organocatalysis. Berlin, April 2007. PrefaceManfred T Reetz, Benjamin List, Stefan Jaroch, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Dihydroquinolines as novel n-NOS inhibitorsStefan Jaroch, Peter Hölscher, Hartmut Rehwinkel, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitorsStefan Jaroch, Peter Hölscher, Hartmut Rehwinkel, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2010
Discovery of quinolines as selective glucocorticoid receptor agonistsStefan Jaroch, Markus Berger, Christoph Huwe, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2017
Discovery of new selective glucocorticoid receptor agonist leadsMarkus Berger, Hartmut Rehwinkel, Norbert Schmees, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Fluorinated dihydroquinolines as potent n-NOS inhibitorsStefan Jaroch, Hartmut Rehwinkel, Peter Hölscher, et al.
Pageof 2